Gastric Adenocarcinoma with Peritoneal Carcinomatosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-01-23
Clinical Trial Update: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas [Phase 2]
Phase 2 clinical trial update for catumaxomab in gastric adenocarcinoma with peritoneal carcinomatosis has completed recruitment/status.